Core Viewpoint - Meidike (688079.SH) reported a significant increase in revenue for the first half of 2025, but continued to face net losses, indicating challenges in profitability despite revenue growth [1][2]. Financial Performance - The company achieved operating revenue of 291 million yuan in the first half of 2025, representing a year-on-year increase of 35.05% compared to 215 million yuan in the same period last year [2][4]. - The net profit attributable to shareholders was a loss of 50.63 million yuan, slightly higher than the loss of 50.59 million yuan in the previous year [2][4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of 52.36 million yuan, compared to a loss of 40.21 million yuan in the same period last year [4]. - The net cash flow from operating activities was 77.16 million yuan, showing a significant increase of 55.74% from 49.54 million yuan in the previous year [4]. Historical Performance - In 2024, the company reported operating revenue of 486 million yuan, a year-on-year increase of 51.38%, but incurred a net loss of 102 million yuan, compared to a loss of 84.45 million yuan in the previous year [4]. - In 2023, the company experienced a decline in operating revenue to 321 million yuan, a decrease of 22.48%, with a net loss of 84.45 million yuan, compared to a profit of 22.09 million yuan in the previous year [4]. Capital Raising and Stock Issuance - Meidike went public on the Sci-Tech Innovation Board on March 2, 2021, issuing 100 million shares at a price of 10.19 yuan per share, raising a total of 1.022 billion yuan [5]. - The company plans to use the raised funds for the construction of an optical optoelectronic component production base and a research and development center, with excess funds allocated for repaying bank loans or supplementing working capital [5]. - On April 30, 2025, the company announced a proposal to authorize the board to issue stock to specific investors, with a total financing amount not exceeding 300 million yuan [6].
美迪凯连亏2年半 上市即巅峰募10亿拟定增募不超3亿